Droperidol's Effect on QT Interval

Journal of Perianesthesia Nursing

Volumn 21, Issue 2, 2006, Pages 82-87

  Martinez, Jason B ^a   Moos, Daniel D ^a   Dahlen, Larry L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CENTRAL DEPRESSANT AGENT; DROPERIDOL;

ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG CONTRAINDICATION; DRUG LABELING; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HUMAN; LONG QT SYNDROME; NURSE ATTITUDE; ORGANIZATION AND MANAGEMENT; POSTANESTHESIA NURSING; RISK FACTOR; TORSADE DES POINTES; UNITED STATES;

ADJUVANTS, ANESTHESIA; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIEMETICS; DROPERIDOL; DRUG LABELING; DRUG MONITORING; HUMANS; LONG QT SYNDROME; NURSE'S ROLE; POSTANESTHESIA NURSING; RISK FACTORS; TORSADES DE POINTES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33646009170     PISSN: 10899472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jopan.2006.02.002     Document Type: Article

References (24)

1. United States Food and Drug Administration. Inapsine dear doc letter, December 4, 2001. Available at: http://www.fda.gov/medwatch/safety/2001/inapsine.htm. Accessed March 07, 2002.
2. Young D. FDA advisory panel discusses droperidol concerns. Am J Health Syst Pharm 61 (2004) 219-222
3. American Regent Laboratories, Inc. Droperidol Injection, USP product insert. Reference number IN9702. Revised 1/02.
4. Drolet B., Zhang S., Deschenes D., et al. Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current. J Cardiovasc Electrophysiol 10 (1999) 1597-1604
5. Kao L.W., Kirk M.A., Evers S.J., et al. Droperidol, QT prolongation, and sudden death. What is the evidence?. Ann Emerg Med 41 (2003) 546-558
6. Pandit S.K., Kothary S.P., Pandit U.A., et al. Dose-response study of droperidol and metoclopramide as antiemetics for outpatient anesthesia. Anesth Analg 68 (1999) 789-802
7. Caldwell M.A. Pharmacology of intravenous agents. McIntosh Essentials of Nurse Anesthesia (1997), St Louis, McGraw-Hill 61 LW
8. Moss A. QTc interval prolongation. is it beneficial or harmful?. Am J Cardiol 72 (1993) 23B-25B
9. Lischke V., Bhene M., Doelken P., et al. Droperidol causes a dose-dependent prolongation of the QT interval. Anesth Analg 79 (1994) 983-986
10. Viskin S. Long QT syndromes and torsades de pointes. Lancet 354 (1999) 1625-1633
11. Morganroth J. QTc interval prolongation. Is it beneficial or harmful?. Am J Cardiol 72 (1993) 1B-3B
12. Faigel D.O., Metz D.C., and Kochman M.L. Torsades de pointes complicating the treatment of bleeding esophageal varices. Association with neuroleptics, vasopressin, and electrolyte imbalance. Am J Gastroenterol 90 (1995) 822-824
13. Gbadebo T.D., Trimble R.W., Khoo M.S.C., et al. Calmodulin inhibitor ω-7 unmasks a novel electrocardiographic parameter that predicts initiation of torsades de pointes. Circulation 105 (2002) 770-774
14. Tan H.L., Hou C.J.Y., Lauer M.R., et al. Electrophysiologic mechanisms of the long QT interval syndromes and torsades de pointes. Ann Intern Med 122 (1995) 701-714
15. Moss A., Schwartz P.J., Crampton R.S., et al. The long QT syndrome prospective longitudinal study of 328 families. Circulation 84 (1991) 1136-1144
16. Holmberg S., and Chamberlain D.A. Cardiac arrest and cardiopulmonary resuscitation. In: Julian D.G., Camm A.J., and Fox K.A. (Eds). Diseases of the Heart (1996), Saunders, Philadelphia 1459-1481
17. White R.D. Cardiopulmonary resuscitation. Basic and advanced cardiac life support. In: Miller R.D. (Ed). Anesthesia (2000), Churchill-Livingstone, Philadelphia 2533-2559
18. Buckley N.A., and Sanders P. Cardiovascular adverse effects of antipsychotic drugs. Drug Safety 23 (2000) 215-228
19. Lawrence K.R., and Nasraway S.A. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill. A review of the literature. Pharmacotherapy 17 (1997) 531-537
20. Reilly J.G., Ayis S.A., Ferrier I.N., et al. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355 (2000) 1048-1052
21. White P.F., Song D., Abrao J., et al. Effect of low-dose droperidol on the QT interval during and after general anesthesia. Anesthesiology 102 (2005) 1101-1105
22. Charbit B., Albaladejo P., Funck-Brentano C., et al. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 102 (2005) 1094-1100
23. Horowitz B.Z., Bizovi K., and Moreno R. Droperidol-behind the black box warning. Acad Emerg Med 9 (2002) 615-618
24. University of Arizona Center for Education and Research on Therapeutics. Drugs to be avoided by congenital long QT patients. Available at: http://www.torsades.org/. Accessed March 15, 2005